- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ion Beam Applications SA (IBAB)
Ion Beam Applications SA stock price live, this page displays EBR IBAB stock exchange data. View the IBAB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ion Beam Applications SA real time stock price chart below.
What Is the Ion Beam Applications SA Stock Price Today?
The Ion Beam Applications SA stock price today is 15.76.
What Is the Stock Symbol for Ion Beam Applications SA?
The stock symbol for Ion Beam Applications SA is "IBAB."
What Stock Exchange Does Ion Beam Applications SA Trade On?
Ion Beam Applications SA is listed and trades on the Brussels stock exchange.
Is Ion Beam Applications SA a Good Stock to Buy?
Determining whether Ion Beam Applications SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBAB quote. (ISIN: BE0003766806)
What Is the Ion Beam Applications SA Stock Price Today?
The Ion Beam Applications SA stock price today is 15.76.
What Is the Stock Symbol for Ion Beam Applications SA?
The stock symbol for Ion Beam Applications SA is "IBAB."
What Stock Exchange Does Ion Beam Applications SA Trade On?
Ion Beam Applications SA is listed and trades on the Brussels stock exchange.
Is Ion Beam Applications SA a Good Stock to Buy?
Determining whether Ion Beam Applications SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBAB quote. (ISIN: BE0003766806)
Brussels
Currency in EUR
15.76
+0.04(+0.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.56
16.04
52 wk Range
9.90
16.04
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.5616.04
52 wk Range
9.9016.04
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IBAB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
15.75
Downside
-0.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- IBA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- IBA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.75
(-0.06% Downside)
Ion Beam Applications SA Earnings Call Summary for Q3/2025
- IBA reported Q3 2025 order intake of €195 million (+€11M YoY), maintained a €1.3B backlog, and secured €135M in financing to strengthen its balance sheet.
- The company acquired Phantomics to enhance medical imaging capabilities and signed an MoU with Varian to improve proton therapy interoperability.
- Despite regulatory pressures in ETO sterilization, IBA maintains strong positioning in proton therapy, particularly in the APAC region.
- Management reaffirmed 2025 guidance of at least $25M EBIT, with CFO Catherine Vandenborre highlighting promising developments in theranostics.
- IBA expects gradual improvement in net financial position starting December 2025, with proton therapy projects extending beyond 2026.
Last Updated: 2025-11-20, 11:18 a/m
Read Full TranscriptEarnings
Latest Release
Mar 27, 2026
EPS / Forecast
-- / --
Revenue / Forecast
315.3M / --
Compare IBAB to Peers and Sector
Metrics to compare | IBAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIBABPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.0x | 22.2x | −0.5x | |
PEG Ratio | 1.06 | 0.51 | 0.00 | |
Price/Book | 3.6x | 2.2x | 2.6x | |
Price / LTM Sales | 0.7x | 2.5x | 3.1x | |
Upside (Analyst Target) | 3.4% | 32.2% | 52.5% | |
Fair Value Upside | Unlock | −1.5% | 6.0% | Unlock |
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation and energy switching while the gantry is rotating; Proteus ONE, a compact proton therapy system transforming cancer treatment; Proteus PLUS, a proton therapy solution for cancer centers; and dosimetry solutions that includes radiation therapy; medical imaging; and QUASAR that offers a portfolio of sophisticated phantoms supporting MR guided radiation therapy, motion management, surface guided radiation therapy, geometric distortion analysis, and machine targeting solutions. It also offers radio pharma solutions, including radioisotopes, cyclotrons, and radiochemistry, as well as other integrated and industrial solutions, and services. In addition, the company is involved in construction of proton therapy, and other accelerators equipment and installation services; and operation and maintenance services, as well as sales a license for intellectual property. The company has strategic research and development partnership with SCK CEN, a Belgian nuclear research center focusing on the development of Actinium-225, a radioactive isotope for the treatment of cancer. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ion Beam Applications (IBAB) Stock Price Today?
The Ion Beam Applications stock price today is 15.76 EUR.
What Stock Exchange Does Ion Beam Applications Trade On?
Ion Beam Applications is listed and trades on the Brussels Stock Exchange.
What Is the Stock Symbol for Ion Beam Applications?
The stock symbol for Ion Beam Applications is "IBAB."
Does Ion Beam Applications Pay Dividends? What’s The Current Dividend Yield?
The Ion Beam Applications dividend yield is 1.09%.
What Is the Ion Beam Applications Market Cap?
As of today, Ion Beam Applications market cap is 459.08M EUR.
What Is Ion Beam Applications's Earnings Per Share (TTM)?
The Ion Beam Applications EPS (TTM) is 0.42.
From a Technical Analysis Perspective, Is IBAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ion Beam Applications Stock Split?
Ion Beam Applications has split 1 times.
How Many Employees Does Ion Beam Applications Have?
Ion Beam Applications has 2039 employees.
What is the current trading status of Ion Beam Applications (IBAB)?
As of May 26, 2026, Ion Beam Applications (IBAB) is trading at a price of 15.76 EUR, with a previous close of 15.72 EUR. The stock has fluctuated within a day range of 15.56 EUR to 16.04 EUR, while its 52-week range spans from 9.90 EUR to 16.04 EUR.
What Is Ion Beam Applications (IBAB) Price Target According to Analysts?
The average 12-month price target for Ion Beam Applications is 15.75 EUR, with a high estimate of 18.5 EUR and a low estimate of 12 EUR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -0.06% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.